Institutional members access full text with Ovid®

Share this article on:

Osteogenic Melanoma With Desmin Expression

Trevisan, Flávia MD, MSc*; Tregnago, Aline C. MD; Lopes Pinto, Clóvis A. MD, PhD; Urvanegia, Ana C. M. MSc; Morbeck, Diogo L. MD; Bertolli, Eduardo MD, MSc; Riva Neto, Floriano R. MD; Duprat Neto, João P. MD, PhD; de Macedo, Mariana P. MD, PhD

American Journal of Dermatopathology: July 2017 - Volume 39 - Issue 7 - p 528–533
doi: 10.1097/DAD.0000000000000719
Brief Report

Background: Osteogenic differentiation is rarely seen in melanomas, when it occurs it is mainly in acral lesions.

Methods: We report a case of an osteogenic melanoma in a 49-year-old woman who presented with a pigmented lesion in the subungueal region of her left hallux. The lesion was ulcerated and infiltrated until the deep dermis without bone involvement.

Results: The tumor was composed of pleomorphic atypical epithelioid and fusiform cells disposed in nests or cords, with vesicular nuclei and prominent central nucleoli. Focal lentiginous proliferation of large atypical melanocytes was present along the dermoepidermal junction. Areas of osteoid matrix focally mineralized were disposed in trabeculae, and there were islands of neoplastic cells. Immunohistochemistry revealed strong expression of S-100 protein and, unexpectedly, of desmin. Focal expression of Melan-A, microphthalmia transcription factor, and HMB-45 is also revealed. Mutations in BRAF and NRAS genes were not present. The patient was submitted to an amputation of the left hallux with negative sentinel lymph node.

Conclusion: The importance of recognizing osteogenic melanoma is based on difficulties for histologic recognition and its differentials diagnosis.

*Department of Dermatology, Hospital de Clinicas da UFPR, Curitiba, Brazil;

Departments of Anatomic Pathology, and

Skin Cancer, A. C. Camargo Cancer Center, São Paulo, Brazil.

Reprints: Flávia Trevisan, MD, MSc, 181th, Marechal Mallet Street, São José dos Pinhais 83005530, Paraná, Brazil (e-mail: draflaviatrevisan@gmail.com).

The authors declare no conflicts of interest.

Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.